StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet Information
StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet is an allopathic medicine The correct dosage of StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
- StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet Benefits & Uses
- StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet Dosage & How to Take
- StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet Side Effects
- StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet Related Warnings
- Severe Interaction of StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet with Other Drugs
- StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet Contraindications
- Frequently asked Questions about StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet
- StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet Interactions with Food and Alcohol
StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet Benefits & Uses
StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet is used to treat the following -
Main Benefits
- Diabetes (Read More - 10 Home Remedies for Diabetes)
StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet Dosage & How to Take
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet Side Effects
Based on research, the following side effects have been observed when StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet is used -
Severe
- Anemia (Read More - Home Remedies for Anaemia)
- Hypoglycemia (Low blood sugar level)
Common
- Headache
- Nausea or vomiting
- Dizziness (Read More - Home Remedies for Dizziness: Quick Tips for Instant Relief)
- Stomach ache (Read More - Home remedies for stomach pain)
StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet Related Warnings
-
Is the use of StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet safe for pregnant women?
No research has not been done till date on the safety of StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet for pregnant women. So its effects on pregnant women are unknown.
Unknown -
Is the use of StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet safe during breastfeeding?
StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet is completely safe for breastfeeding women.
Safe -
What is the effect of StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet on the Kidneys?
StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
Moderate -
What is the effect of StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet on the Liver?
There may be an adverse effect on the liver after taking StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
Moderate -
What is the effect of StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet on the Heart?
StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet may have mild side effects on the heart. Most people will never see any effect on the heart.
Mild
Severe Interaction of StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet with Other Drugs
StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet Contraindications
If you are suffering from any of the following diseases, you should not take StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet unless your doctor advises you to do so -
- Heart Disease
- Kidney Disease
- Liver Disease
- Anemia
Frequently asked Questions about StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet
-
Is this StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet habit forming or addictive?
StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet is not addictive in nature.
No -
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet. So it is best to avoid driving.
Dangerous -
Is it safe?
StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet is safe but it is important to consult a doctor before taking it.
Safe, but take only on Doctor's advise -
Is it able to treat mental disorders?
No, StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet cannot treat any kind of mental disorder.
No
StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet Interactions with Food and Alcohol
-
Interaction between Food and StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet
Due to the absence of research, it is difficult to say how StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet and food will interact.
Unknown -
Interaction between Alcohol and StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet
Information about the interaction of StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet and alcohol is not currently available because this topic has not been researched yet.
Unknown
See all substitutes for StayHappi Metformin HCl Prolonged Release + Glimepiride Tablet
- Zoryl M 2 Tablet PR (20) - ₹300
- Zoryl M 1 Tablet PR (20) - ₹214
- Gluconorm G2 Tablet PR - ₹303
- Gluconorm G1 Tablet PR - ₹196
- Gluconorm G2 Forte Tablet PR - ₹239
- Gluconorm G Plus 3 Tablet PR - ₹230
- Gluconorm G 0.5 Forte Tablet PR - ₹130
- Gluconorm G1 Forte Tablet PR - ₹204
- Azulix 3 MF Tablet PR - ₹177
- Zoryl M 3 Forte Tablet PR (15) - ₹244
- Gluconorm G 4 Forte Tablet PR - ₹262
- Azulix 1 MF Tablet PR - ₹153
- Gluconorm G Plus 1 Tablet PR - ₹158
- Zoryl M2 Forte Tablet PR (15) - ₹224
- Zoryl M 3/500 Tablet PR (15) - ₹256
- Gluconorm G3 Tablet PR - ₹273
- Gluconorm G3 Forte Tablet - ₹260
- Azulix 1 MF Forte Tablet PR - ₹186
- Zoryl M 4 Forte Tablet PR (15) - ₹257
- Gluconorm G 0.5 Tablet PR - ₹114
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826